SABCS 2021 Conference Coverage on VuMedi


 

Final Findings From the CONTROL Trial of Diarrheal Prophylaxis or Neratinib Dose Escalation on Neratinib-Associated Diarrhea and Tolerability in HER2+ EBC

196 views
March 21, 2022
Comments 0
Login to view comments. Click here to Login